Teva “spread information contradicted by health authorities’ findings, seeking to sow doubt on the safety, efficacy and therapeutic equivalence of the rival product,” the EU Commission said.

Some two years after the European Commission accused Teva of meddling with the competition for its former multiple sclerosis blockbuster Copaxone, the other shoe has finally dropped. The European ...

10 (UPI) --Teva Pharmaceuticals ... the U.S. Department of Transportation announced Tuesday. Oct. 30 (UPI) -- Walking across a street without using a crosswalk no longer will be punished in ...

The management of Israeli pharma group Teva has laid out its strategy for a return to growth after a challenging few years, with a greater emphasis on innovative medicines and a focus on complex ...

Many people use the same pair of shoes for all workouts, but it's worth having a separate pair specifically for walking. According to Accardi, it can help prevent injury if you're logging a lot of ...

Oct. 31 (UPI) --The European Commission fined Teva Pharmaceuticals $503 million for delaying competition posed by rival generic drugmakers, the company's second major financial penalty this month.

We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Kontra Investment Xchange’s Substack by Kontra. In this article, we will summarize the bulls’ thesis on TEVA.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

But if you pick the right... The average of price targets set by Wall Street analysts indicates a potential upside of 25.1% in Teva Pharmaceutical Industries (TEVA). While the effectiveness of ...

BOSTON (Reuters) - Teva Pharmaceutical Industries Ltd (TEV.SG) has agreed to pay $450 million to resolve allegations it used charities that help cover Medicare patients' out-of-pocket drug costs ...

BRUSSELS (AP) — The European Commission said Thursday it has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its ...

1 Day TEVA 2.63% DJIA 0.65% S&P 500 0.27% Health Care/Life Sciences -0.41% ...